Literature DB >> 32081448

Conjugation of peptides to short-acyl-chain ceramides for delivery across mucosal cell barriers.

Richard I Duclos1, Kiara D Blue2, Michael J Rufo3, Xiaoling Chen4, Jason J Guo5, Xiaoyu Ma6, Wayne I Lencer7, Daniel J F Chinnapen8.   

Abstract

Robust transport of therapeutic peptides and other medicinal molecules across tight epithelial barriers would overcome the major obstacle to oral delivery. We have already demonstrated that peptides conjugated to gangliosides (GM1 and GM3) having non-native short N-acyl groups hijack the endogenous process of intracellular lipid sorting resulting in transcytosis and delivery across epithelial barriers in vitro and in vivo. Here, we report synthetic methodologies to covalently conjugate peptides directly to short-acyl-chain C6-ceramides. We found that the short-acyl-chain ceramide domain is solely responsible for transcytosis in vitro. This clarifies and expands the platform of short-acyl-chain sphingolipids for conjugated peptide delivery across tight mucosal cell barriers from gangliosides to just the ceramide itself.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  C(6)-ceramide; Oral peptide delivery; Short-acyl-chain; Transcytosis

Mesh:

Substances:

Year:  2020        PMID: 32081448      PMCID: PMC7174066          DOI: 10.1016/j.bmcl.2020.127014

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  23 in total

1.  The total synthesis of ganglioside GM3.

Authors:  R I Duclos
Journal:  Carbohydr Res       Date:  2000-10-06       Impact factor: 2.104

Review 2.  Preclinical development of a C6-ceramide NanoLiposome, a novel sphingolipid therapeutic.

Authors:  Mark Kester; Jocelyn Bassler; Todd E Fox; Carly J Carter; Jeff A Davidson; Mylisa R Parette
Journal:  Biol Chem       Date:  2015-06       Impact factor: 3.915

Review 3.  Therapeutic peptides: Historical perspectives, current development trends, and future directions.

Authors:  Jolene L Lau; Michael K Dunn
Journal:  Bioorg Med Chem       Date:  2017-07-01       Impact factor: 3.641

4.  Identification of tight junction modulating lipids.

Authors:  Shu-Chih Chen-Quay; Kristine T Eiting; Angela W-A Li; Najib Lamharzi; Steven C Quay
Journal:  J Pharm Sci       Date:  2009-02       Impact factor: 3.534

5.  Rapid oxime and hydrazone ligations with aromatic aldehydes for biomolecular labeling.

Authors:  Anouk Dirksen; Philip E Dawson
Journal:  Bioconjug Chem       Date:  2008-12       Impact factor: 4.774

6.  Physicochemical and biological characterization of ceramide-containing liposomes: paving the way to ceramide therapeutic application.

Authors:  Elena Khazanov; Aba Priev; Joris P Shillemans; Yechezkel Barenholz
Journal:  Langmuir       Date:  2008-05-30       Impact factor: 3.882

Review 7.  The sphingolipid salvage pathway in ceramide metabolism and signaling.

Authors:  Kazuyuki Kitatani; Jolanta Idkowiak-Baldys; Yusuf A Hannun
Journal:  Cell Signal       Date:  2007-12-14       Impact factor: 4.315

8.  Unsaturated glycoceramides as molecular carriers for mucosal drug delivery of GLP-1.

Authors:  Yvonne M te Welscher; Daniel J-F Chinnapen; Lydia Kaoutzani; Randall J Mrsny; Wayne I Lencer
Journal:  J Control Release       Date:  2013-12-23       Impact factor: 9.776

9.  Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice.

Authors:  Guangfu Li; Dai Liu; Eric T Kimchi; Jussuf T Kaifi; Xiaoqiang Qi; Yariswamy Manjunath; Xinjian Liu; Tye Deering; Diego M Avella; Todd Fox; Don C Rockey; Todd D Schell; Mark Kester; Kevin F Staveley-O'Carroll
Journal:  Gastroenterology       Date:  2018-01-31       Impact factor: 22.682

10.  Transcytosis Assay for Transport of Glycosphingolipids across MDCK-II Cells.

Authors:  Maria Daniela Garcia-Castillo; Wayne I Lencer; Daniel J-F Chinnapen
Journal:  Bio Protoc       Date:  2018-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.